Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bioanalysis ; 2(6): 1041-9, 2010 Jun.
Article in English | MEDLINE | ID: mdl-21083207

ABSTRACT

Long-term stability is a basic parameter in bioanalytical method validation; however, no criteria for conducting long-term stability studies are specified in current guidelines. We present an evaluation of a modified statistical approach applied to a study design utilizing an isochronic analysis (collection of samples to be analyzed at one time point) to determine the long-term stability and, further, a comparison with the most widely used continuous design. The presented approach has been used in regulated bioanalysis at Lundbeck for the past 7 years and has, in this period, been applied to 121 studies; all providing conclusive data. The isochronic approach eliminates day-to-day variation, reduces labor and adds to the flexibility in the laboratory. The statistical evaluation used is based on the relative difference between baseline samples and stability test samples as well as 90% confidence intervals for the mean concentration for each of the stability test points.


Subject(s)
Drug Stability , Freezing , Animals , Dogs , Humans , Mice , Pharmaceutical Preparations/blood , Rabbits , Rats , Time Factors
2.
Br J Psychiatry ; 189: 264-72, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16946363

ABSTRACT

BACKGROUND: It is uncertain whether higher doses of selective serotonin reuptake inhibitors have greater efficacy in generalised anxiety disorder. AIMS: To assess the efficacy of different doses of escitalopram in generalised anxiety disorder. METHOD: Randomised, double-blind, placebo-controlled, fixed-dose, parallel-group, 12-week study, with 681 patients: placebo (n=139); escitalopram, 5 mg/day, (n=134); 10 mg/day (n=136); 20 mg/day (n=133); paroxetine, 20 mg/day (n=139). RESULTS: Mean change in the primary efficacy measure was greater with escitalopram 10 and 20 mg than with placebo; 10 mg was more efficacious than paroxetine. Paroxetine was superior to placebo on some secondary measures, at some time points. Compared with placebo, more patients withdrew because of adverse events with escitalopram 20 mg and paroxetine. CONCLUSIONS: Escitalopram was efficacious in generalised anxiety disorder, 20 was not significantly superior to 10 mg/day. Escitalopram 10 mg was more efficacious than paroxetine.


Subject(s)
Anxiety Disorders/drug therapy , Citalopram/administration & dosage , Paroxetine/administration & dosage , Selective Serotonin Reuptake Inhibitors/administration & dosage , Adult , Aged , Citalopram/adverse effects , Double-Blind Method , Female , Humans , Male , Middle Aged , Paroxetine/adverse effects , Selective Serotonin Reuptake Inhibitors/adverse effects , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...